A Population Genetic Model for the Initial Spread of Partially Resistant Malaria Parasites under Anti-Malarial Combination Therapy and Weak Intrahost Competition
Open Access
- 9 July 2014
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 9 (7) , e101601
Abstract
To develop public-health policies that extend the lifespan of affordable anti-malarial drugs as effective treatment options, it is necessary to understand the evolutionary processes leading to the origin and spread of mutations conferring drug resistance in malarial parasites. We built a population-genetic model for the emergence of resistance under combination drug therapy. Reproductive cycles of parasites are specified by their absolute fitness determined by clinical parameters, thus coupling the evolutionary-genetic with population-dynamic processes. Initial mutations confer only partial drug-resistance. Therefore, mutant parasites rarely survive combination therapy and within-host competition is very weak among parasites. The model focuses on the early phase of such unsuccessful recurrent mutations. This ends in the rare event of mutants enriching in an infected individual from which the successful spread of resistance over the entire population is initiated. By computer simulations, the waiting time until the establishment of resistant parasites is analysed. Resistance spreads quickly following the first appearance of a host infected predominantly by mutant parasites. This occurs either through a rare transmission of a resistant parasite to an uninfected host or through a rare failure of drugs in removing “transient” mutant alleles. The emergence of resistance is delayed with lower mutation rate, earlier treatment, higher metabolic cost of resistance, longer duration of high drug dose, and higher drug efficacy causing a stronger reduction in the sensitive and resistant parasites’ fitnesses. Overall, contrary to other studies’ proposition, the current model based on absolute fitness suggests that aggressive drug treatment delays the emergence of drug resistance.Keywords
This publication has 43 references indexed in Scilit:
- Predicting mosquito infection from Plasmodium falciparum gametocyte density and estimating the reservoir of infectioneLife, 2013
- Multiple populations of artemisinin-resistant Plasmodium falciparum in CambodiaNature Genetics, 2013
- Genetic loci associated with delayed clearance of Plasmodium falciparum following artemisinin treatment in Southeast AsiaProceedings of the National Academy of Sciences, 2012
- The evolution of drug resistance and the curious orthodoxy of aggressive chemotherapyProceedings of the National Academy of Sciences, 2011
- Environmental, pharmacological and genetic influences on the spread of drug-resistant malariaProceedings Of The Royal Society B-Biological Sciences, 2010
- An analytical model for genetic hitchhiking in the evolution of antimalarial drug resistanceTheoretical Population Biology, 2010
- CHEMOTHERAPY, WITHIN-HOST ECOLOGY AND THE FITNESS OF DRUG-RESISTANT MALARIA PARASITESEvolution, 2010
- The dynamics of mutations associated with anti-malarial drug resistance in Plasmodium falciparumTrends in Parasitology, 2009
- Artemisinin Resistance inPlasmodium falciparumMalariaNew England Journal of Medicine, 2009
- Competitive release and facilitation of drug-resistant parasites after therapeutic chemotherapy in a rodent malaria modelProceedings of the National Academy of Sciences, 2007